This project is primarily funded by EDCTP2.
EDCTP2 number: RIA2018CO-2515
DATURA is registered in ClinicalTrial.gov : NCT04738812
The funding period began: 01.05.2020
The project also receives support from Inserm-ANRS for its Asian component.
is to contribute to the reduction of the individual, social and economic burden of poverty-related infectious diseases in sub-Saharan Africa, by funding clinical research for medical tools to detect, treat and prevent poverty-related infectious diseases in this region. The programme specifically aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat HIV/AIDS, tuberculosis, malaria and other poverty-related infectious diseases, including neglected infectious diseases and emerging or re-emerging infectious diseases, prevalent in sub-Saharan Africa.
EDCTP’s second programme (EDCTP2 2014-2024)
supports all clinical trial phases (I-IV) including health services optimisation research. Research and regulatory capacity development remain integrated in EDCTP2’s research funding strategy aiming to strengthen the conditions for conducting clinical research in sub-Saharan Africa. The overall objective of EDCTP2 is to contribute to the reduction of the social and economic burden of poverty-related diseases in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for this region in partnership with researchers and institutions in sub- Saharan Africa.
The programme is supported under Horizon 2020,
the European Union’s Framework Programme for Research and Innovation. It will also contribute to the United Nations’ Sustainable Development Goals (SDGs) and represents a major commitment of the EU’s 30 Partner States to that end. While the promotion of health is only one of the 17 goals (SDG3: ‘Ensure healthy lives and promote well-being for all at all ages’), the achievement of the other SDGs is affected by or depends significantly on people’s good health, including vulnerable and neglected ones. Improved health and its attendant economic benefits will contribute to multiple social and economic goals.